1. Home
  2. ELSE vs AKTX Comparison

ELSE vs AKTX Comparison

Compare ELSE & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electro-Sensors Inc.

ELSE

Electro-Sensors Inc.

N/A

Current Price

$4.40

Market Cap

16.0M

Sector

Industrials

ML Signal

N/A

Logo Akari Therapeutics plc ADS

AKTX

Akari Therapeutics plc ADS

HOLD

Current Price

$0.39

Market Cap

14.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELSE
AKTX
Founded
1968
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.0M
14.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ELSE
AKTX
Price
$4.40
$0.39
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$3.30
AVG Volume (30 Days)
2.9K
1.4M
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.12
N/A
Revenue
$9,787,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$38.90
N/A
Revenue Growth
5.36
N/A
52 Week Low
$3.65
$0.26
52 Week High
$5.50
$1.73

Technical Indicators

Market Signals
Indicator
ELSE
AKTX
Relative Strength Index (RSI) 36.67 39.04
Support Level $4.48 $0.26
Resistance Level $4.70 $0.47
Average True Range (ATR) 0.06 0.07
MACD -0.01 0.01
Stochastic Oscillator 0.00 38.34

Price Performance

Historical Comparison
ELSE
AKTX

About ELSE Electro-Sensors Inc.

Electro-Sensors Inc manufactures and sells industrial production monitoring and process control systems. It manufactures a complete line of monitoring and control systems for a wide range of industrial machine applications. The systems measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its products include motor drive control, position monitors, sensor targets, signal conditioners, speed sensors, speed switches, tachometers, temperature sensors, vibration monitors, etc.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

Share on Social Networks: